TherapeuticsMD (TXMD) Current Deferred Revenue (2012 - 2014)

TherapeuticsMD has reported Current Deferred Revenue for 3 years, with the latest figure at $522613.0 in Q4 2014.

• For the quarter ending Q4 2014, Current Deferred Revenue fell 67.39% year-over-year to $522613.0; the trailing twelve-month figure through Dec 2014 stood at $522613.0 (down 67.39% YoY), and the FY2014 full-year result was $522613.0, down 67.39% from the prior year.
• Current Deferred Revenue for Q4 2014 stood at $522613.0, down from $1.6 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $1.6 million in Q4 2013, with the low at $522613.0 in Q4 2014.
• Historically, Current Deferred Revenue has averaged $955520.7 across 3 years, with a median of $922151.0 in 2012.
• Annual changes were most pronounced in 2013 — Current Deferred Revenue soared 39.99% — and 2014, when it sank 67.39%.
• TherapeuticsMD's Current Deferred Revenue stood at $1.1 million in 2012, then jumped by 39.99% to $1.6 million in 2013, then slumped by 67.39% to $522613.0 in 2014.
• The last three Current Deferred Revenue figures came in at $522613.0 (Q4 2014), $1.6 million (Q4 2013), and $1.1 million (Q1 2013), per Business Quant data.